Tag: RANI

Company

Rani Therapeutics Holdings Inc (NASDAQ: RANI) Forecast To Gain 95.7% To Hit Consensus Price Target

Rani Therapeutics Holdings Inc (NASDAQ:RANI) has a beta value of -0.02 and has seen 11.46 million shares traded in the last trading session. The company,

Science

During The Past Six Months, Rani Therapeutics Holdings Inc (NASDAQ: RANI) Shares Took An -54.97% Jump. Here Is What We Should Expect

During the last session, Rani Therapeutics Holdings Inc (NASDAQ:RANI)’s traded shares were 0.52 million, with the beta value of the company hitting -0.01. At the

Business

Rani Therapeutics Holdings Inc (NASDAQ:RANI) Is Down -33.17 Percent Over The Past 30 Days: What’s Next?

In last trading session, Rani Therapeutics Holdings Inc (NASDAQ:RANI) saw 0.38 million shares changing hands with its beta currently measuring 0.00. Company’s recent per share

Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.

Tag: RANI

Rani Therapeutics Holdings Inc (NASDAQ: RANI) Forecast To Gain 95.7% To Hit Consensus Price Target

During The Past Six Months, Rani Therapeutics Holdings Inc (NASDAQ: RANI) Shares Took An -54.97% Jump. Here Is What We Should Expect

Rani Therapeutics Holdings Inc (NASDAQ:RANI) Is Down -33.17 Percent Over The Past 30 Days: What’s Next?

Quick Links

Categories